|
 |
Initial Phase I/II trastuzumab trials
|
| |
Pivotal Phase III trastuzumab trial
|
| |
Preclinical data on trastuzumab/chemotherapy
combinations
|
| |
Phase II trials of trastuzumab/chemotherapy
combinations
|
| |
Cardiotoxicity with different chemotherapy combinations |
| |
Carboplatin or cisplatin plus docetaxel/trastuzumab
(CTH) |
| |
Preclinical data on trastuzumab/hormonal therapy
combinations |
| |
Duration of trastuzumab therapy |
| |
Use of trastuzumab for metastatic disease |
| |
Adjuvant trastuzumab trials |
| |
Neoadjuvant trastuzumab trials |
| |
Assessing HER2 status |
| |
|
| |
A chronology of select
breast cancer publications by Dr Slamon |
| |
| |
San Antonio
Breast Cancer Symposium
Clinical Trials Exhibit.
|
|
|
|
